Codexis Inc (CDXS) 1.55 $CDXS
Codexis Reports Financial Results for the First Quarter of 2014
GlobeNewswire - Wed May 07, 3:45PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the first quarter ended March 31, 2014.
Codexis to Announce First Quarter 2014 Financial Results on May 7, 2014
GlobeNewswire - Wed Apr 30, 3:12PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, May 7, 2014 at 4:30 p.m. Eastern Time to discuss its first quarter 2014 financial results. The call and webcast will follow the release of fourth quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
LifeSci Advisors Initiates Coverage of Codexis, Inc.
eTeligis - Thu Apr 17, 9:01AM CDT
LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Codexis, Inc. (NASDAQ:CDXS), a leader in biocatalysis focused on using their enzyme engineering platform to streamline chemical transformations for the pharmaceutical and fine chemicals industries. Biocatalysis is a low cost, safe, and environmentally friendly alternative to conventional chemistry approaches for manufacturing drugs. Codexis integrates itself early in the drug discovery process by offering comprehensive kits of enzymes for customers to sample, and specializes in customizing enzymes using their proprietary CodeEvolver(R) technology to rapidly deliver the desired process improvements. The Company has helped transform the manufacturing processes for several leading drugs, and has won three Presidential Green Chemistry Challenge Awards, which is more than any other company other than the manufacturing giants Dow, BASF, and Merck, who have each also won three.
Global Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Report - Forecasts & Opportunities to 2018
M2 - Wed Apr 02, 6:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qtvfx/alcohol_and) has announced the addition of the "Alcohol and Starch/Sugar Enzyme Market by Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. This research report provides a comprehensive analysis of the global alcohol and starch/sugar enzymes market, which witnesses faster growth on account of its diverse applications in the industrial and specialty sector. Massive investments in research and development for new products drive the demand for alcohol and starch/sugar enzymes, tremendously. This report also describes the key players in alcohol and starch/sugar enzymes business across the globe. The regions covered include North America (U.S., Canada, and Mexico), Europe (U.K., Germany, France, Italy, and Spain), Asia-Pacific, and Rest of the World (South Africa and Brazil). The report is focused on the detailed study of the types and applications of alcohol and starch/sugar enzymes in different geographical regions, with a thorough analysis of the market players in the alcohol and starch/sugar enzymes business. Novozymes (Denmark), DuPont (U.S.), Roquette Freres (France), Dyadic International Inc. (U.S.), Amano Enzymes Inc. (Japan), Advanced Enzymes Technologies Ltd. (India), ABF Plc. (U.K.), The Soufflet group (France), Codexis Inc. (U.S.), Lesaffre (France), etc., are the key players in the alcohol and starch/sugar enzymes industry.The recent development strategies of these key playershave been studied. Asia-Pacific is projected to be the fastest-growing market for alcohol and starch/sugar enzymes. The U.S. wine market is the world's second largest market, which is estimated toincrease the demand of alcohol enzymes to process wine. The U.S. is the most important contributor for the growth of starch/sugar enzymes market in North America. Extensive investments are made in research and development to develop advanced products so that the maximum market share can be occupied by introducing new and improved products to suffice the customers' demands. The market for alcohol and starch/sugar enzymes is anticipated to generate significant amounts of revenues considering the rise indemand for food and beverages, biofuels, cleaning agents, pharmaceuticals, biocatalysts, along with research & biotechnology products. The Asia-Pacific region is witnessing a steady demand for alcohol and starch/sugar enzymes due to the expansion strategies of global industrial and pharmaceutical companies situated in this region. Rapid industrialization and development in infrastructure as well as co-operation from local governments has driven the market for alcohol and starch/sugar enzymes in the Asia-Pacific region. The U.S. is a key market in the North American region for alcohol and starch/sugar enzymes due to extensive pharmaceuticals production and research & biotechnology applications. The growth strategies of market players have been identified and analyzed. The manufacturers are exploring the Asia-Pacific and Latin American markets for potential customers. Scope of the Report Type - Carbohydrases - Protease - Lipases - Others Application - Alcohol enzymes - - Industrial - - Specialty - Starch/sugar enzymes - - Industrial - - Specialty Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insights - Alcohol & Starch/Sugar Enzymes Market, By Type - Alocohol & Starch/Sugar Enzymes Market, By Application - Alcohol & Starch/Sugar Enzymes Market, By Geography - Competitive Landscape - Company Profiles - ABF Plc - Advanced Enzyme Technology Ltd. - Amano Enzyme Inc. - Codexis Inc. - Dupont De Nemours & Co. (Dupont) Msds - Dyadic International Inc. - Lesaffre - Novozymes A/S - Roquette Freres - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/2q...lcohol_and
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Industrial Enzymes Market by Types (Carbohydrase, Protease, Lipase) & Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed) to 2018
M2 - Wed Mar 19, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n84g3h/industrial) has announced the addition of the "Industrial Enzymes Market by Types, Applications, & Geography - Global Trends & Forecasts to 2018" report to their offering. The global industrial enzymes market consists of various enzymes, which can be broadly categorized as carbohydrases, proteases, lipases, and others. Carbohydrase is the fastest growing segment of this market in terms of growth rate. Carbohydrases form the major class of enzymes that catalyzes the breakdown of carbohydrates into simple sugar. They also account for the largest market share in the food and beverage, detergent, and textile industry. Other sub-types of types of carbohydrases include amylase, cellulose, lactase, and pectinase. Enzymes are gaining importance in various industrial products and processes due to effective catalytic properties exhibited by them. New developments in biotechnology and protein engineering provide a platform for the development of new enzymes efficiently; hence new enzymes with improved properties are increasingly being used for technical applications as well as in the unexplored field of their usage. One of the important uses of industrial enzymes is in the cleaning agents industry. Proteases, amylases, lipases, and celluloses are used for this purpose. These enzymes render powerful stain removing techniques and other benefits such as fabric care, whiteness, and color fastened fabrics. Enzymes have been extensively used in animal feed additives to provide healthy feed supplements for feed products. The global industrial enzymes market has observed significant developments in from 2012 to 2013. The industry has observed various key players entering into agreements and collaborations to enhance their research capabilities and to further extend their product portfolio. North America was the biggest market for industrial enzymes, followed by Europe due to maximum key players situated in these regions as well as the increasing demand for higher yield enzymes to suffice the growing demand for cleaning agents, biofuels, food and beverages, as well as textiles, paper & pulp processing, etc. The core technology that has helped expand the industrial enzyme industry is genetic engineering. It has paved a way to exploit new types of enzymes and new source organisms, which has in turn helped in cost reduction, development, and production of enzymes. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Executive Summary 5 Premium Insights 6 Global Industrial Enzymes Market, By Type 7 Global Industrial Enzymes, By Application 8 Industrial Enzyme Market, By Geography 9 Competitive Landscape 10 Company Profiles - Abf Plc. - Amano Enzyme Inc. - Basf - Chr. Hansen Holding A/S - Codexis Inc. - Dsm - Dupont De Nemours & Co. (Dupont) Msds. - Dyadic International Inc. - Novozymes A/S - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/n84g3h/industrial
Intrexon Acquires Laboratory Operations from Codexis and Expands Presence to Europe
PR Newswire Europe - Mon Mar 17, 2:01AM CDT
-- Company Increases Bioproduction Capabilities and Capacity
Codexis Sells Its Hungarian Operations to Intrexon Corporation
GlobeNewswire - Thu Mar 13, 3:30PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction.
Codexis Reports Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Tue Mar 11, 3:04PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013.
Dyadic Withdraws Notice Of Breach Letter Relating To Its C1 License Agreement With Codexis
PR Newswire - Mon Mar 10, 3:38PM CDT
Dyadic International, Inc. ("Dyadic"
(OTC Pink: DYAI), a global biotechnology company, announced today that it received notice from Codexis, Inc. that it will no longer be pursuing its advanced biofuels program. This notice is consistent with Codexis' previous public announcement on November 12, 2013 that it was immediately winding down its advanced biofuels program.
Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
GlobeNewswire - Thu Feb 27, 6:45AM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry.
Gas Exploration to Start April in Tanga
by Nestory Ngwega - All Africa Global Media - Wed Feb 26, 12:33AM CST
TANGA Regional Commissioner Ms Chiku Gallawa announced that exploration of gas and oil in the region's coastal belt will start in April, this year. Ms Gallawa said the exercise was initially scheduled to start last month, but was delayed to enable the exploration company have more time for preparations.
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
GlobeNewswire - Tue Feb 25, 3:02PM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2013 financial results for the period ended December 31, 2013. The call and webcast will follow the release of fourth quarter and fiscal year financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
Aurigene and Pierre Fabre Pharmaceuticals Announce a Licensing Agreement for a New Cancer Therapeutic in Immuno-oncology: AUNP12, an Immune Checkpoint Modulator Targeting the PD-1 Pathway
PR Newswire - Thu Feb 13, 2:14AM CST
Pierre Fabre, the third largest French pharmaceutical company, and Aurigene, a leading biotech company based in India, today announced that the two companies have entered into a collaborative license, development and commercialization agreement granting Pierre Fabre global Worldwide rights (excluding India) to a new immune checkpoint modulator, AUNP-12.
Codexis to Present at 16th Annual BIO CEO & Investor Conference
GlobeNewswire - Tue Feb 04, 9:49PM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 16 Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York City.
5 Stocks Under $10 Set to Soar
at The Street - Thu Jan 23, 1:15PM CST
These under-$10 stocks look ready to trade higher from current levels.
2 Biotech Stocks Under $10 Triggering Breakouts
at The Street - Wed Jan 08, 6:00AM CST
Keep these under-$10 biotech stock on your radar.
Global Specialty Enzymes Strategic Business Report 2013-2018: Proteases, Polymerases, Carbohydrases & Others
M2 - Tue Nov 19, 9:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/tm4s6c/specialty_enzymes#summary) has announced the addition of the "Specialty Enzymes - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: - Proteases - Polymerases - Carbohydrases - Other Specialty Enzymes. Specific end-use segments also analyzed are: - Pharmaceuticals & Diagnostics - Research/Biotechnology - Others. The report profiles 43 companies including many key and niche players such as: - Advanced Enzymes Technologies Limited - Advanced Vital Enzymes Ltd. - Amano Enzyme Inc. - AST Enzymes - Biocatalysts Ltd. - BBI Solutions - Chr. Hansen Holding AS - Codexis, Inc. - Genzyme Corporation - Life Technologies Corporation - Meteoric Life Sciences - National Enzyme Company - ROCHE Holding, Inc. - Specialty Enzymes & Biotechnologies Co. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends, Issues And Drivers 3. Overall (Industrial And Specialty) Enzymes Market: A Macro Perspective 4. Product Overview 5. Product Introductions/Innovations 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 43 (including Divisions/Subsidiaries - 48) - The United States (23) - Canada (1) - Japan (4) - Europe (11) - - France (1) - - Germany (1) - - The United Kingdom (3) - - Spain (1) - - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/tm...es#summary
Codexis Reports Financial Results for the First Quarter of 2014
GlobeNewswire - Wed May 07, 3:45PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the first quarter ended March 31, 2014.
Codexis to Announce First Quarter 2014 Financial Results on May 7, 2014
GlobeNewswire - Wed Apr 30, 3:12PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Wednesday, May 7, 2014 at 4:30 p.m. Eastern Time to discuss its first quarter 2014 financial results. The call and webcast will follow the release of fourth quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
LifeSci Advisors Initiates Coverage of Codexis, Inc.
eTeligis - Thu Apr 17, 9:01AM CDT
LifeSci Advisors, LLC, a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage of Codexis, Inc. (NASDAQ:CDXS), a leader in biocatalysis focused on using their enzyme engineering platform to streamline chemical transformations for the pharmaceutical and fine chemicals industries. Biocatalysis is a low cost, safe, and environmentally friendly alternative to conventional chemistry approaches for manufacturing drugs. Codexis integrates itself early in the drug discovery process by offering comprehensive kits of enzymes for customers to sample, and specializes in customizing enzymes using their proprietary CodeEvolver(R) technology to rapidly deliver the desired process improvements. The Company has helped transform the manufacturing processes for several leading drugs, and has won three Presidential Green Chemistry Challenge Awards, which is more than any other company other than the manufacturing giants Dow, BASF, and Merck, who have each also won three.
Global Alcohol and Starch/Sugar Enzyme (Carbohydrase, Protease, and Lipase) Report - Forecasts & Opportunities to 2018
M2 - Wed Apr 02, 6:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2qtvfx/alcohol_and) has announced the addition of the "Alcohol and Starch/Sugar Enzyme Market by Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. This research report provides a comprehensive analysis of the global alcohol and starch/sugar enzymes market, which witnesses faster growth on account of its diverse applications in the industrial and specialty sector. Massive investments in research and development for new products drive the demand for alcohol and starch/sugar enzymes, tremendously. This report also describes the key players in alcohol and starch/sugar enzymes business across the globe. The regions covered include North America (U.S., Canada, and Mexico), Europe (U.K., Germany, France, Italy, and Spain), Asia-Pacific, and Rest of the World (South Africa and Brazil). The report is focused on the detailed study of the types and applications of alcohol and starch/sugar enzymes in different geographical regions, with a thorough analysis of the market players in the alcohol and starch/sugar enzymes business. Novozymes (Denmark), DuPont (U.S.), Roquette Freres (France), Dyadic International Inc. (U.S.), Amano Enzymes Inc. (Japan), Advanced Enzymes Technologies Ltd. (India), ABF Plc. (U.K.), The Soufflet group (France), Codexis Inc. (U.S.), Lesaffre (France), etc., are the key players in the alcohol and starch/sugar enzymes industry.The recent development strategies of these key playershave been studied. Asia-Pacific is projected to be the fastest-growing market for alcohol and starch/sugar enzymes. The U.S. wine market is the world's second largest market, which is estimated toincrease the demand of alcohol enzymes to process wine. The U.S. is the most important contributor for the growth of starch/sugar enzymes market in North America. Extensive investments are made in research and development to develop advanced products so that the maximum market share can be occupied by introducing new and improved products to suffice the customers' demands. The market for alcohol and starch/sugar enzymes is anticipated to generate significant amounts of revenues considering the rise indemand for food and beverages, biofuels, cleaning agents, pharmaceuticals, biocatalysts, along with research & biotechnology products. The Asia-Pacific region is witnessing a steady demand for alcohol and starch/sugar enzymes due to the expansion strategies of global industrial and pharmaceutical companies situated in this region. Rapid industrialization and development in infrastructure as well as co-operation from local governments has driven the market for alcohol and starch/sugar enzymes in the Asia-Pacific region. The U.S. is a key market in the North American region for alcohol and starch/sugar enzymes due to extensive pharmaceuticals production and research & biotechnology applications. The growth strategies of market players have been identified and analyzed. The manufacturers are exploring the Asia-Pacific and Latin American markets for potential customers. Scope of the Report Type - Carbohydrases - Protease - Lipases - Others Application - Alcohol enzymes - - Industrial - - Specialty - Starch/sugar enzymes - - Industrial - - Specialty Key Topics Covered: - Introduction - Executive Summary - Market Overview - Premium Insights - Alcohol & Starch/Sugar Enzymes Market, By Type - Alocohol & Starch/Sugar Enzymes Market, By Application - Alcohol & Starch/Sugar Enzymes Market, By Geography - Competitive Landscape - Company Profiles - ABF Plc - Advanced Enzyme Technology Ltd. - Amano Enzyme Inc. - Codexis Inc. - Dupont De Nemours & Co. (Dupont) Msds - Dyadic International Inc. - Lesaffre - Novozymes A/S - Roquette Freres - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/2q...lcohol_and
Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018
M2 - Thu Mar 20, 3:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cpjrtc/specialty_enzymes) has announced the addition of the "Specialty Enzymes Market by Source, Type, Application & Geography - Global Trends & Forecasts to 2018" report to their offering. Specialty enzymes are natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates by decreasing the amount of energy required to form a complex of reactants that is competent to produce reaction products. Specialty enzymes according to their type are classified as carbohydrases, proteases, polymerases and nucleases, lipases, and others. Specialty enzymes report covers analysis of the market structure by identifying various sub-segments of the global specialty enzymes market, Revenue forecasts of the global specialty enzymes markets and its various sub-markets/micro-markets with respect to four main regions- North America, Europe, Asia-Pacific, and Rest of the World (RoW). Major trends, drivers, and restraints of the global specialty enzymes market are identified and explained in detail. The specialty enzyme markets include pharmaceutical, research and biotechnology, diagnostics and biocatalysts. Pharmaceutical manufacturers are witnessing increased awareness in incorporating biocatalysis into manufacturing processes. Enzymes are particularly useful to generate isomerically pure pharmaceuticals and fine chemicals In spite of numerous advantages of biocatalysis, manufacturers have been slow to adopt industrial-scale enzymatic approaches. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview Global Specialty Enzymes Market, By Source Specialty Enzyme Market, By Type Specialty Enzyme Market, By Application Specialty Enzymes Market, By Geography Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Advanced Enzyme Technology Ltd. - Affymetrix Inc. - Amano Enzyme Inc. - Basf - Bbi Enzymes Ltd. - Codexis Inc. - Life Technologies - Nagase & Co. Ltd. - Roche Holding Ag. - Sanofi S.A. For more information visit http://www.researchandmarkets.com/research/cp...ty_enzymes About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Industrial Enzymes Market by Types (Carbohydrase, Protease, Lipase) & Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed) to 2018
M2 - Wed Mar 19, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n84g3h/industrial) has announced the addition of the "Industrial Enzymes Market by Types, Applications, & Geography - Global Trends & Forecasts to 2018" report to their offering. The global industrial enzymes market consists of various enzymes, which can be broadly categorized as carbohydrases, proteases, lipases, and others. Carbohydrase is the fastest growing segment of this market in terms of growth rate. Carbohydrases form the major class of enzymes that catalyzes the breakdown of carbohydrates into simple sugar. They also account for the largest market share in the food and beverage, detergent, and textile industry. Other sub-types of types of carbohydrases include amylase, cellulose, lactase, and pectinase. Enzymes are gaining importance in various industrial products and processes due to effective catalytic properties exhibited by them. New developments in biotechnology and protein engineering provide a platform for the development of new enzymes efficiently; hence new enzymes with improved properties are increasingly being used for technical applications as well as in the unexplored field of their usage. One of the important uses of industrial enzymes is in the cleaning agents industry. Proteases, amylases, lipases, and celluloses are used for this purpose. These enzymes render powerful stain removing techniques and other benefits such as fabric care, whiteness, and color fastened fabrics. Enzymes have been extensively used in animal feed additives to provide healthy feed supplements for feed products. The global industrial enzymes market has observed significant developments in from 2012 to 2013. The industry has observed various key players entering into agreements and collaborations to enhance their research capabilities and to further extend their product portfolio. North America was the biggest market for industrial enzymes, followed by Europe due to maximum key players situated in these regions as well as the increasing demand for higher yield enzymes to suffice the growing demand for cleaning agents, biofuels, food and beverages, as well as textiles, paper & pulp processing, etc. The core technology that has helped expand the industrial enzyme industry is genetic engineering. It has paved a way to exploit new types of enzymes and new source organisms, which has in turn helped in cost reduction, development, and production of enzymes. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Executive Summary 5 Premium Insights 6 Global Industrial Enzymes Market, By Type 7 Global Industrial Enzymes, By Application 8 Industrial Enzyme Market, By Geography 9 Competitive Landscape 10 Company Profiles - Abf Plc. - Amano Enzyme Inc. - Basf - Chr. Hansen Holding A/S - Codexis Inc. - Dsm - Dupont De Nemours & Co. (Dupont) Msds. - Dyadic International Inc. - Novozymes A/S - The Soufflet Group For more information visit http://www.researchandmarkets.com/research/n84g3h/industrial
Intrexon Acquires Laboratory Operations from Codexis and Expands Presence to Europe
PR Newswire Europe - Mon Mar 17, 2:01AM CDT
-- Company Increases Bioproduction Capabilities and Capacity
Codexis Sells Its Hungarian Operations to Intrexon Corporation
GlobeNewswire - Thu Mar 13, 3:30PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the sale of its subsidiary in Hungary to Intrexon Corporation. The transaction closed on March 13, 2014, with a purchase price of $1.5 million. No proprietary Codexis materials or intellectual property were included in the transaction.
Codexis Reports Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Tue Mar 11, 3:04PM CDT
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced its financial results for the fourth quarter and year ended December 31, 2013.
Dyadic Withdraws Notice Of Breach Letter Relating To Its C1 License Agreement With Codexis
PR Newswire - Mon Mar 10, 3:38PM CDT
Dyadic International, Inc. ("Dyadic"
(OTC Pink: DYAI), a global biotechnology company, announced today that it received notice from Codexis, Inc. that it will no longer be pursuing its advanced biofuels program. This notice is consistent with Codexis' previous public announcement on November 12, 2013 that it was immediately winding down its advanced biofuels program. Codexis Appoints Biopharmaceuticals Industry Veteran, Patrick Yang, Ph.D., to Board of Directors
GlobeNewswire - Thu Feb 27, 6:45AM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Patrick Yang, Ph.D., to its board of directors. Dr. Yang brings significant experience in pharmaceutical manufacturing and process development to the Codexis board, following several executive leadership roles within the pharmaceutical industry.
Gas Exploration to Start April in Tanga
by Nestory Ngwega - All Africa Global Media - Wed Feb 26, 12:33AM CST
TANGA Regional Commissioner Ms Chiku Gallawa announced that exploration of gas and oil in the region's coastal belt will start in April, this year. Ms Gallawa said the exercise was initially scheduled to start last month, but was delayed to enable the exploration company have more time for preparations.
Codexis to Announce Fourth Quarter and Fiscal Year 2013 Financial Results on March 11, 2014
GlobeNewswire - Tue Feb 25, 3:02PM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will host a live conference call and audio webcast on Tuesday, March 11, 2014 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2013 financial results for the period ended December 31, 2013. The call and webcast will follow the release of fourth quarter and fiscal year financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
Aurigene and Pierre Fabre Pharmaceuticals Announce a Licensing Agreement for a New Cancer Therapeutic in Immuno-oncology: AUNP12, an Immune Checkpoint Modulator Targeting the PD-1 Pathway
PR Newswire - Thu Feb 13, 2:14AM CST
Pierre Fabre, the third largest French pharmaceutical company, and Aurigene, a leading biotech company based in India, today announced that the two companies have entered into a collaborative license, development and commercialization agreement granting Pierre Fabre global Worldwide rights (excluding India) to a new immune checkpoint modulator, AUNP-12.
Codexis to Present at 16th Annual BIO CEO & Investor Conference
GlobeNewswire - Tue Feb 04, 9:49PM CST
Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and complex chemistry industries, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 16 Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014 at 1:00 p.m. ET in New York City.
5 Stocks Under $10 Set to Soar
at The Street - Thu Jan 23, 1:15PM CST
These under-$10 stocks look ready to trade higher from current levels.
2 Biotech Stocks Under $10 Triggering Breakouts
at The Street - Wed Jan 08, 6:00AM CST
Keep these under-$10 biotech stock on your radar.
Global Specialty Enzymes Strategic Business Report 2013-2018: Proteases, Polymerases, Carbohydrases & Others
M2 - Tue Nov 19, 9:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/tm4s6c/specialty_enzymes#summary) has announced the addition of the "Specialty Enzymes - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following Product Segments: - Proteases - Polymerases - Carbohydrases - Other Specialty Enzymes. Specific end-use segments also analyzed are: - Pharmaceuticals & Diagnostics - Research/Biotechnology - Others. The report profiles 43 companies including many key and niche players such as: - Advanced Enzymes Technologies Limited - Advanced Vital Enzymes Ltd. - Amano Enzyme Inc. - AST Enzymes - Biocatalysts Ltd. - BBI Solutions - Chr. Hansen Holding AS - Codexis, Inc. - Genzyme Corporation - Life Technologies Corporation - Meteoric Life Sciences - National Enzyme Company - ROCHE Holding, Inc. - Specialty Enzymes & Biotechnologies Co. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends, Issues And Drivers 3. Overall (Industrial And Specialty) Enzymes Market: A Macro Perspective 4. Product Overview 5. Product Introductions/Innovations 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 43 (including Divisions/Subsidiaries - 48) - The United States (23) - Canada (1) - Japan (4) - Europe (11) - - France (1) - - Germany (1) - - The United Kingdom (3) - - Spain (1) - - Rest of Europe (5) - Asia-Pacific (Excluding Japan) (9) For more information visit http://www.researchandmarkets.com/research/tm...es#summary
